Teleflex has sold a significant portion of its respiratory device business to Medline for $286 million in cash, the company said June 28.
The Wayne, Pa.-based devicemaker said the respiratory device product line generated $139 million in revenue in 2020.
Teleflex expects a revenue headwind of $28 million to $32 million in 2021 as a result of the deal. The company said it intends to use money from the deal with Medline to pay down its debt and support growth.
Read the full news release here.